Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Universitätsklinik für Innere Medizin
Klinische Abteilung für Hämatologie
SCI/PUBMED gelistet | alle Publikationstypen | Gesamt nach Jahr und Erstautor | MUG-Autor*innen |
** = Publikationen gelistet in SCI/SSCI/Pubmed
Originalarbeit (Zeitschrift)
** Benda, MA; Ulmer, H; Weger, R; Reimann, P; Lang, TRS; Pichler, P; Winder, T; Hartmann, B; Strassl, I; Krauth, MT; Agis, H; Sormann, S; Podar, K; Willenbacher, W; Willenbacher, E
Attrition Rates in Multiple Myeloma Treatment under Real World Conditions-An Analysis from the Austrian Myeloma Registry (AMR)
CANCERS. 2023; 15(3): 962
Doi: 10.3390/cancers15030962
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Bruch, PM; Dietrich, S; Finel, H; Boumendil, A; Greinix, H; Heinicke, T; Bethge, W; Beelen, D; Schmid, C; Martin, H; Castagna, L; Scheid, C; Schafer-Eckart, K; Bittenbring, J; Finke, J; Sengeloev, H; Heiblig, M; Cornelissen, J; Chevallier, P; Mohty, M; Robinson, S; Montoto, S; Dreger, P
Retrospective analysis of hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: conditioning intensity matters
LEUKEMIA. 2023;
Doi: 10.1038/s41375-022-01782-z
Web of Science
PubMed
FullText
FullText_MUG
** Foßelteder, J; Pabst, G; Sconocchia, T; Schlacher, A; Auinger, L; Kashofer, K; Beham-Schmid, C; Trajanoski, S; Waskow, C; Schöll, W; Sill, H; Zebisch, A; Wölfler, A; Thomas, D; Reinisch, A
Human gene-engineered calreticulin mutant stem cells recapitulate MPN hallmarks and identify targetable vulnerabilities.
Leukemia. 2023;
Doi: 10.1038/s41375-023-01848-6
Web of Science
PubMed
FullText
FullText_MUG
** Hodl, I; Sallegger, C; Forstner, P; Sareban, N; Moritz, M; Dreo, B; Schulz, E; Lackner, A; Kleinhappl, B; Hatzl, S; Moazedi-Fürst, F; Seifert-Held, T; Heschl, B; Khalil, M; Enzinger, C; Greinix, H; Stradner, MH; Steinmetz, I; Schlenke, P; Fessler, J
Altered cellular immune response to vaccination against SARS-CoV-2 in patients suffering from autoimmunity with B-cell depleting therapy.
Microbes Infect. 2023; 105103
Doi: 10.1016/j.micinf.2023.105103
[OPEN ACCESS]
PubMed
FullText
FullText_MUG
** Karner, C; Anders, I; Vejzovic, D; Szkandera, J; Scheipl, S; Deutsch, AJA; Weiss, L; Vierlinger, K; Kolb, D; Kühberger, S; Heitzer, E; Habisch, H; Zhang, F; Madl, T; Reininger-Gutmann, B; Liegl-Atzwanger, B; Rinner, B
Targeting epigenetic features in clear cell sarcomas based on patient-derived cell lines.
J Transl Med. 2023; 21(1): 54
Doi: 10.1186/s12967-022-03843-4
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Oleshko, O; Werwitzke, S; Klingberg, A; Witte, T; Eichler, H; Klamroth, R; Holstein, K; Hart, C; Pfrepper, C; Knoebl, P; Greil, R; Neumeister, P; Reipert, BM; Tiede, A
Targets of autoantibodies in acquired hemophilia A are not restricted to factor VIII: data from the GTH-AH 01/2010 study
BLOOD ADV. 2023; 7(1): 122-130.
Doi: 10.1182/bloodadvances.2022008071
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Terbuch, A; Walser, G; Stotz, M; Gerger, A; Posch, F; Bauernhofer, T
Primary Thromboprophylaxis and the Risk of Venous Thromboembolic Events in Patients With Testicular Germ Cell Tumors Treated With Cisplatinum-Based Chemotherapy.
Clin Genitourin Cancer. 2023; 21(1):24-31
Doi: 10.1016/j.clgc.2022.10.005
Web of Science
PubMed
FullText
FullText_MUG
** Thomas, D; Wu, M; Nakauchi, Y; Zheng, M; Thompson-Peach, CAL; Lim, K; Landberg, N; Köhnke, T; Robinson, N; Kaur, S; Kutyna, M; Stafford, M; Hiwase, D; Reinisch, A; Peltz, G; Majeti, R
Dysregulated Lipid Synthesis by Oncogenic IDH1 Mutation Is a Targetable Synthetic Lethal Vulnerability.
Cancer Discov. 2023; 13(2):496-515
Doi: 10.1158/2159-8290.CD-21-0218
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Thompson-Peach, CAL; Foßelteder, J; Reinisch, A; Thomas, D
Thrombopoietin-independent Megakaryocyte Differentiation of Hematopoietic Progenitor Cells from Patients with Myeloproliferative Neoplasms.
Bio Protoc. 2023; 13(2):e4592
Doi: 10.21769/BioProtoc.4592
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Editorial
** Seidel, MG; Brcic, L; Hoefler, G; Hutter, C; Minkov, M; Steffen, LS; Zebisch, A; Benesch, M
Concurrence of a kinase-dead BRAF and an oncogenic KRAS gain-of-function mutation in juvenile xanthogranuloma.
Pediatr Blood Cancer. 2023; 70(4):e30060
Doi: 10.1002/pbc.30060
Web of Science
PubMed
FullText
FullText_MUG